Study guide
3.4: Sterile Compounding & Pharmaceutical Microbiology
Overseas Pharmacist Readiness Assessment OPRA
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1: About the OPRA Exam 1.2: Study and Preparation Strategy for OPRA
2 Chapter 2: Biomedical Sciences
2.1: Human Physiology & Homeostasis 2.2: Pathophysiology of Major Organ Systems 2.3: Medical Microbiology & Infectious Pathogens 2.4: Immunology & Immunotherapy 2.5: Body Fluids, Electrolytes, & Acid-Base Balance 2.6: Physiological Values & Clinical Lab Interpretations
3 Chapter 3: Medicinal Chemistry & Biopharmaceutics
3.1: Physicochemical Properties of Drugs 3.2: Biopharmaceutics & Formulation Science 3.3: Chemical Stability & Storage of Pharmaceuticals 3.4: Sterile Compounding & Pharmaceutical Microbiology
4 Chapter 4: Pharmacokinetics & Pharmacodynamics
4.1: Principles of Pharmacokinetics (Absorption & Distribution) 4.2: Drug Metabolism & Elimination Pathways 4.3: Quantitative Pharmacokinetics (Vd, Clearance, Half-life, Steady-state) 4.4: Clinical Pharmacokinetics (Dosing Adjustments & Non-linear Kinetics) 4.5: Pharmacodynamics & Receptor Theory
5 Chapter 5: Pharmacology & Toxicology
5.1: Mechanisms of Action: Cardiovascular & Renal Agents 5.2: Mechanisms of Action: Respiratory, CNS, & Endocrine Agents 5.3: Adverse Drug Reactions & Drug-Drug Interactions 5.4: Clinical Toxicology & Poisoning Management 5.5: Pharmacogenomics & Genetic Polymorphism
6 Chapter 6: Therapeutics & Patient Care
6.1: Pharmaceutical Calculations: Doses & Unit Conversions 6.2: Pharmaceutical Calculations: Infusions, Percentages, & Tonicity 6.3: Cardiovascular Therapeutics (Hypertension, Heart Failure, Dyslipidemia) 6.4: Anticoagulation & Antiplatelet Therapy 6.5: Endocrine & Metabolic Therapeutics (Diabetes & Thyroid) 6.6: Respiratory Therapeutics (Asthma & COPD) 6.7: Infectious Disease Therapeutics & Antimicrobial Stewardship 6.8: Central Nervous System & Mental Health Therapeutics 6.9: Gastrointestinal & Renal Therapeutics 6.10: Therapeutics in Special Populations: Pregnancy & Lactation 6.11: Therapeutics in Special Populations: Paediatrics & Geriatrics 6.12: Primary Health Care, Self-Care, & Harm Minimisation 6.13: Professional Practice, Ethics, & Communication
3.4: Sterile Compounding & Pharmaceutical Microbiology
Key Takeaways Explain This Topic AI
Aseptic compounding is performed in a Grade A (ISO 5) zone, with horizontal laminar flow hoods for non-hazardous and vertical cytotoxic hoods for hazardous agents.
Sterilisation methods must align with drug stability: autoclaving for heat-stable aqueous preparations, dry heat for non-aqueous oils/powders, and 0.22-micrometer filtration for thermolabile liquids.
Pyrogens are heat-stable endotoxins from Gram-negative bacteria that survive standard sterilisation and are detected using the quantitative LAL test or in vivo rabbit pyrogen test.
Last updated: July 2026
- 3.4: Sterile Compounding & Pharmaceutical Microbiology
- Cleanroom Classifications and Airflow Systems
Sterile compounding involves the preparation of medications that must be completely free of viable microorganisms and particulate matter. In Australia, sterile compounding in hospital and manufacturing pharmacies must adhere to the PIC/S Guide to Good Practices for Preparation of Medicinal Products in Healthcare Establishments (PE 010) and the Pharmacy Board of Australia guidelines.
Cleanroom Grading (PIC/S vs. ISO)
The compounding environment is controlled using particulate-filtered air and classified into different grades depending on the level of cleanliness required.
PIC/S Grade ISO Class Equivalent Maximum Permitted Particles ( ≥ 0.5 μ m / m 3 \ge 0.5\ \mu\text{m} / m^3 ≥ 0.5 μ m / m 3 ) At Rest Maximum Permitted Particles ( ≥ 0.5 μ m / m 3 \ge 0.5\ \mu\text{m} / m^3 ≥ 0.5 μ m / m 3 ) In Operation Common Applications
Grade A ISO 5 3,520 3,520 Local zone for high-risk operations (e.g., aseptic filling, compounding zone in a laminar flow hood).
Grade B ISO 7 (at rest) 3,520 352,000 Background environment for the Grade A zone (e.g., cleanroom/buffer room).
Grade C ISO 8 (in operation) 352,000 3,520,000 Preparation of solutions to be filtered; clean area for less critical stages.
Grade D ISO 8 (at rest) 3,520,000 Not defined Handling of starting materials; anteroom/gowning area.
Laminar Airflow Hoods (LAFH)
Laminar airflow hoods provide a Grade A working environment by passing air through a High-Efficiency Particulate Air (HEPA) filter, which removes 99.97% of particles ≥ 0.3 μ m \ge 0.3\ \mu\text{m} ≥ 0.3 μ m in size. Air flows in parallel lines at a constant velocity (~0.45 m/s).
Horizontal LAFH: Air is drawn through a pre-filter, passes through the HEPA filter at the back of the hood, and blows horizontally forward across the work surface toward the operator.
Use: Preparation of non-hazardous sterile products (e.g., intravenous fluids, total parenteral nutrition [TPN]).
Precaution: Never use for hazardous drugs (cytotoxics, hormones, radiopharmaceuticals), as air is blown directly at the operator.
Vertical LAFH (Cytotoxic Cabinets / Biosafety Cabinets): Air passes through a HEPA filter at the top of the hood and blows downward onto the work surface, where it is drawn into grilles at the front and back.
Use: Compounding hazardous substances (e.g., chemotherapy agents like methotrexate). This setup protects the product from contamination and the operator from inhaling aerosolised drug particles.
Aseptic Technique and the First Air Principle
Aseptic technique refers to the methods used to maintain the sterility of components and pathways during compounding.
The First Air Principle
"First air" is the clean, undisturbed air exiting the HEPA filter. It is free of particulate matter and microorganisms.
Critical Sites: The parts of sterile components that must not be touched or obstructed (e.g., the needle shaft, needle hub, syringe plunger, ampoule neck, and vial rubber septum).
Obstruction and Turbulence: Placing hands, vials, or waste paper between the HEPA filter and a critical site blocks the first air. This causes turbulence and creates a low-pressure wake that pulls contaminated room air onto the critical site, compromising sterility.
In a horizontal hood: Never place hands or objects behind a critical site.
In a vertical hood: Never place hands or objects directly above a critical site.
Gowning and Cleaning Protocols
Gowning Sequence (Anteroom Grade D to Buffer Room Grade B): Remove jewelry, perform hand hygiene (using chlorhexidine or isopropyl alcohol-based scrubs), don shoe covers, hairnet, mask, gown, and finally, sterile gloves. Sanitise gloves frequently with sterile 70% Isopropyl Alcohol (IPA) during compounding.
Hood Sanitation: Clean the LAFH at the start of each shift, before each batch, and after any spill. Wipe with sterile water to remove residues, followed by sterile 70% IPA. Wipe surfaces from top to bottom, and from back (nearest the HEPA filter) to front. Avoid spraying the HEPA filter directly, as this can damage the paper membrane.
Methods of Sterilisation
Sterilisation is the complete destruction or removal of all viable microorganisms, including bacterial spores. The choice of method depends on the chemical and physical characteristics of the formulation.
1. Moist Heat Sterilisation (Autoclaving)
Mechanism: Coagulates and denatures microbial proteins.
Standard Cycle: 121°C at 15 psi pressure for a minimum of 15 minutes.
Applications: Terminally sterilised aqueous solutions, glassware, surgical instruments.
Limitations: Cannot be used for oils, dry powders (moisture cannot penetrate), or thermolabile drugs.
2. Dry Heat Sterilisation
Mechanism: Dehydrates and oxidises microbial cell components.
Standard Cycle: 160°C for 2 hours or 180°C for 30 minutes.
Applications: Non-aqueous materials (oils, petrolatum, waxes, silicone, dry powders) and glassware.
Depyrogenation: Glassware requires 250 ∘ C 250^\circ\text{C} 25 0 ∘ C for at least 30 minutes to destroy pyrogens.
3. Sterilisation by Filtration
Mechanism: Physical removal of microorganisms by passing the solution through a sterile membrane filter with a nominal pore size of 0.22 µm .
Applications: Thermolabile solutions (e.g., protein formulations, certain eye drops, vitamins).
Limitations: Does not remove viruses, mycoplasmas, or pyrogens.
Quality Control: A bubble point test must be performed on the filter post-filtration. This test measures the pressure required to force air bubbles through a water-saturated membrane. If the bubble point pressure is lower than the manufacturer's specification, the filter is ruptured, and the batch is not sterile.
- Pyrogens and Pyrogen Testing
- Nature of Pyrogens
Pyrogens are fever-producing substances. The most common pyrogens are endotoxins , which are lipopolysaccharides (LPS) derived from the outer cell wall of Gram-negative bacteria (e.g., Pseudomonas aeruginosa , Escherichia coli ).
Stability: Endotoxins are highly water-soluble, heat-stable, and can survive standard autoclaving or 0.22 µm filtration.
Clinical Impact: Injection of pyrogens into the bloodstream induces cytokine release (IL-1, TNF-alpha), leading to fever, chills, hypotension, and potentially fatal septic shock.
Pyrogen Testing Methods
Limulus Amebocyte Lysate (LAL) Test:
Principle: An in vitro test utilizing the blood (amebocytes) of the horseshoe crab ( Limulus polyphemus ). Endotoxins cause a gel clot or chromogenic change in the lysate due to an enzymatic cascade.
Pros: Highly sensitive, rapid, quantitative, and specific for Gram-negative endotoxins.
Cons: Does not detect non-endotoxin pyrogens (e.g., chemical pyrogens, viral/fungal pyrogens).
Rabbit Pyrogen Test:
Principle: An in vivo test where the sample is injected intravenously into three rabbits, and their rectal temperatures are monitored. A specified temperature rise indicates the presence of pyrogens.
Pros: Detects all pyrogens (both endotoxin and non-endotoxin).
Cons: Expensive, slow, qualitative, and involves animal testing.